AUTOMATED PIXEL-BY-PIXEL MAPPING OF DYNAMIC CONTRAST-ENHANCED MR-IMAGES FOR EVALUATION OF OSTEOSARCOMA RESPONSE TO CHEMOTHERAPY - PRELIMINARY-RESULTS

被引：24

作者：

HANNA, SL ^{[1
]}

REDDICK, WE ^{[1
]}

PARHAM, DM ^{[1
]}

GRONEMEYER, SA ^{[1
]}

TAYLOR, JS ^{[1
]}

FLETCHER, BD ^{[1
]}

机构：

[1] ST JUDE CHILDRENS RES HOSP, DEPT DIAGNOST IMAGING, MEMPHIS, TN 38101 USA

来源：

JOURNAL OF MAGNETIC RESONANCE IMAGING | 1993年 / 3卷 / 06期

关键词：

BONE NEOPLASMS; MR; CHEMOTHERAPY; CONTRAST ENHANCEMENT; EXTREMITIES; NEOPLASMS; GADOLINIUM; IMAGE DISPLAY; IMAGE PROCESSING; OSTEOSARCOMA; RAPID IMAGING;

D O I：

10.1002/jmri.1880030609

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

An automated technique for pixel-by-pixel computer mapping of tumor necrosis was developed to improve the accuracy and applicability of dynamic contrast agent-enhanced magnetic resonance (MR) imaging in assessing the response of osteosarcoma to preoperative chemotherapy. The technique was evaluated in nine osteosarcoma patients who underwent MR imaging at diagnosis (n = 7) and after preoperative chemotherapy (n = 9). Sequential FLASH (fast low-angle shot) images of the tumor were obtained in one plane every 15 seconds before and for 3 minutes after gadopentetate dimeglumine injection. A region of interest was selected that included the entire tumor area. Slopes representing percent increase in signal intensity over baseline values per minute were calculated automatically for each pixel and displayed as gray-scale maps of the tumor. Matching histologic maps of each tumor were obtained. Visual region-by-region comparison of the pixel and histologic maps showed a high degree of correlation and the ability of the MR imaging technique to help identify small foci of residual viable tumor.

引用

页码：849 / 853

页数：5

共 12 条

[1] Link MP, Goorin AM, Miser AW, Et al., The effect of adjuvant chemotherapy on relapse‐free survival in patients with osteosarcoma of the extremity, N Engl J Med, 314, pp. 160-1606, (1986)
[2] Eiber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J, Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial, J Clin Oncol, 5, pp. 21-26, (1987)
[3] Rosen G, Caparros B, Huvos AG, Et al., Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy, Cancer, 49, pp. 1221-1230, (1982)
[4] Raymond AK, Chawla SP, Carrasco CH, Et al., Osteosarcoma chemotherapy effect: a prognostic factor, Semin Diagn Pathol, 4, pp. 212-236, (1987)
[5] Erlemann R, Sciuk J, Bosse A, Et al., Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy, Radiology, 175, pp. 791-796, (1990)
[6] Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA, Pediatric musculoskeletal tumors: use of dynamic, contrast‐enhanced MR imaging to monitor response to chemotherapy, Radiology, 184, pp. 243-248, (1992)
[7] de Baere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, di Paola M, Osteosarcoma after chemotherapy: evaluation with contrast material‐enhanced subtraction MR imaging, Radiology, 185, pp. 587-592, (1992)
[8] Bonnerot V, Charpentier A, Frovin F, Kalifa C, Vanel D, Di Paola R, Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy, Invest Radiol, 27, pp. 847-855, (1992)
[9] Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD, Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium‐DTPA‐enhanced magnetic resonance mapping, Invest Radiol, 27, pp. 367-373, (1992)
[10] Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG, Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery, Cancer, 43, pp. 2163-2177, (1979)

← 1 2 →